株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ポイントオブケア (POC) 診断の世界市場

The World Market for Point of Care (POC) Diagnostics

発行 Kalorama Information 商品コード 253350
出版日 ページ情報 英文 401 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.88円で換算しております。
Back to Top
ポイントオブケア (POC) 診断の世界市場 The World Market for Point of Care (POC) Diagnostics
出版日: 2017年02月03日 ページ情報: 英文 401 Pages
概要

当レポートでは、世界のポイントオブケア (POC) 診断の市場について調査し、POC検査の各種タイプ、検査対象・検査内容、検査区分および詳細タイプ別の主な製品、市場規模および市場成長率、競合環境、市場成長の推進因子および課題の分析、主要企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • POC (ポイントオブケア) 検査
  • 産業規制
  • POC産業の推進因子
  • POC検査のタイプ
    • 血液
    • 尿
    • 唾液
    • 毛髪
    • 光学技術
    • 呼気
  • 状況分析:POC診断検査別
    • 心血管系疾病
    • 糖尿病
    • 薬物乱用
    • 感染症
    • 妊娠・受胎能
    • 世界の人口動態
  • 世界の老齢人口

第3章 POC血糖値検査

  • 血糖値検査の各種タイプ
  • 製品
  • 市場規模・成長率
  • 自己検査
  • 専門家による検査
  • 競合分析

第4章 POC血液・電解質検査

  • 血液・電解質検査の各種タイプ
  • 白血球
  • 製品
  • 市場規模・成長率
  • 自己検査
  • 専門家による検査
  • 競合分析

第5章 POC迅速凝固

  • 製品
    • 血小板検査
  • 市場規模・成長率
  • 自己検査
  • 専門家による検査
  • 競合分析

第6章 POC迅速心筋マーカー

  • 製品
  • 市場規模・成長率
  • 競合分析

第7章 POC薬物乱用検査

  • 製品
  • 市場規模・成長率
  • 自己検査
  • 専門家による検査
  • 競合分析

第8章 POC妊娠・受胎能検査

  • 製品
  • 市場規模・成長率
  • 自己検査
  • 専門家による検査
  • 競合分析

第9章 POC結腸癌スクリーニング/便潜血検査

  • 製品
  • 市場規模・成長率
  • 自己検査
  • 専門家による検査
  • 競合分析

第10章 POC感染症検査

  • 製品
  • 市場規模・成長率
  • 自己検査
  • 専門家による検査
  • 競合分析

第11章 POC脂質(コレステロール)検査

  • 製品
  • 自己検査
  • 専門家による検査
  • 競合分析

第12章 POC癌・腫瘍マーカー検査

  • 製品
  • 市場規模・成長率
  • 競合分析

第13章 POC尿ストリップ検査

  • 製品
  • 市場規模・成長率
  • 自己検査
  • 専門家による検査
  • 競合分析

第14章 その他のPOC検査

  • 微生物学的検査
  • TSH
  • アレルギー
  • 自己免疫
  • その他
  • 市場規模・成長率

第15章 課題・動向

  • 概要
  • ウェアラブル機器
  • 呼気検査の進歩
  • 償還における課題
  • 競合
  • POC・分子診断学
  • POC・バイオセンサー・マイクロ流体
  • POCのコネクティビティ
  • 非侵襲性技術の出現
    • 唾液およびスワブ
    • 光学技術

第16章 世界のPOC検査市場・競合分析

  • 市場概要
  • 市場分析:製品カテゴリー別
  • 市場分析:詳細カテゴリー別
  • 自己検査
  • 専門家による検査
  • 市場分析:国別
  • 総論
  • 競合分析

第17章 企業プロファイル

  • 概要
  • ABAXIS, INC.
  • ABBOTT LABORATORIES
  • ABINGDON HEALTH, LTD.
  • ACCRIVA DIAGNOSTICS
  • ACCUBIOTECH CO, LTD.
  • ACON LABORATORIES, INC
  • AERSCHER DIAGNOSTICS, LLC
  • ALERE INC
  • ALFA SCIENTIFIC DESIGNS, INC
  • AMERICAN BIO MEDICA CORPORATION
  • AQUILA DIAGNOSTIC SYSTEMS, INC
  • ARKRAY
  • ARTRON LABORATORIES, INC
  • ATIVA MEDICAL CORPORATION
  • ATLAS GENETICS LTD.
  • ATLAS LINK BIOTECH CO., LTD
  • AUGURIX DIAGNOSTIC
  • AUTOBIO DIAGNOSTICS CO., LTD
  • AXXIN
  • BECKMAN COULTER, INC
  • BIOLYTICAL LABORATORIES
  • BIOMEDOMICS, INC
  • BIOMEME, INC
  • BIOMERICA
  • BIOMERIEUX SA
  • BIOPTIX, INC
  • BIORACLE LIMITED
  • BIOSENSIA
  • CALYPTE BIOMEDICAL CORPORATION
  • CEPHID
  • CHEMBIO DIAGNOSTIC SYSTEMS, INC.
  • CHURCH & DWIGHT CO. INC
  • DAKTARI DIAGNOSTICS
  • DANAHER CORPORATION
  • DEXCOM, INC
  • DNA ELECTRONICS LTD. (DNAE)
  • DRAGERWERK AG & CO. KGAA
  • 栄研化学
  • EKF DIAGNOSTICS HOLDINGS PLC
  • ENIGMA DIAGNOSTICS, LTD.
  • ENTERIX, INC
  • ENTOPSIS
  • EPISTEM/GENEDRIVE
  • EXALENZ BIOSCIENCE LTD.
  • EY LABORATORIES
  • FABPULOUS B.V.
  • FIO CORPORATION
  • HELENA LABORATORIES
  • HEMA DIAGNOSTIC SYSTEMS, LLC
  • INSILIXA, INC
  • INSTRUMENTATION LABORATORY
  • JANT PHARMACAL CORPORATION
  • LAMDAGEN CORPORATION
  • LIFESCAN, INC
  • LIFESIGN, LLC
  • MACHEREY-NAGEL GMBH & CO. KG
  • MAGNASENSE TECHNOLOGIES
  • MBIO DIAGNOSTICS, INC
  • MEDIX BIOCHEMICA
  • MEDMIRA, INC
  • MENARINI DIAGNOSTICS
  • MERIDIAN BIOSCIENCE, INC
  • METAARA MEDICAL TECHNOLOGIES, INC
  • MICRONICS, INC
  • NOVA BIOMEDICAL, CORP.
  • OPKO HEALTH, INC
  • ORASURE TECHNOLOGIES, INC.
  • ORTHO CLINICAL DIAGNOSTICS
  • POLYMED THERAPEUTICS INC.
  • POLYMEDCO, INC
  • POLYMER TECHNOLOGIES, INC (PTS DIAGNOSTICS)
  • QUANTUMDX GROUP LIMITED
  • QUIDEL CORPORATION
  • RADIOMETER MEDICAL A/S
  • RESPONSE BIOMEDICAL CORP
  • RHEONIX, INC
  • ROCHE DIAGNOSTIC CORPORATION
  • SAMSUNG HEALTHCARE
  • SAVYON DIAGNOSTICS
  • SEKISUI DIAGNOSTICS
  • SIEMENS HEALTHINEERS
  • SILOAM BIOSCIENCES, INC
  • SPECTRAL MEDICAL, INC
  • SYSMEX CORPORATION
  • TRINITY BIOTECH PLC
  • VEREDUS LABORATORIES PTE LTD
  • WAVE 80 BIOSCIENCES
  • XAGENIC

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: KLI15242496

Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are transforming the point-of-care (POC) landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient's home. The POC diagnostic industry will be part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine.

Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing. The World Market for Point of Care (POC) Diagnostics focuses on the global market for POC, including the following market information:

  • Global POC Test Market, 2014-2021
  • Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2016
  • Global POC Testing Market Analysis by Product Category, 2016 (Professional, Self-Testing)
  • Global POC Professional Testing Market Analysis by Product Subcategory, 2016 (Drugs of Abuse, Blood & Electrolytes, Glucose, Infectious Disease, Rapid Coagulation, Cardiac Markers, Fecal Occult Blood, Lipid, Pregnancy & Fertility, Miscellaneous, Urine Strip, Cancer, Total)
  • Global POC Self-Testing Market Analysis by Product Category, 2016 (Glucose, Pregnancy & Fertility, Fecal Occult Blood, Rapid Coagulation, Drugs of Abuse, Urine Strip, Infectious Disease, Lipid)
  • POC Testing Analysis by Region/Country, 2016 (United States, Europe, Japan, ROW, Total)
  • POC Testing Market Analysis by European Region, 2016 (Germany, France, UK, Italy, Spain, Others)
  • POC Testing Market Analysis by Rest of World Region/Country, 2016 (China, India, Brazil, Other, Total)

The report features in-depth analysis of the market for the traditional set of POC tests: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening. In the past 5-10 years the following tests were added: HgA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP).

POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. At the same time more decentralized test venues invest in non-waived rapid tests and instruments POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record.

Molecular POC tests in physician office are already available for respiratory infections and more. The capacity to provide precise answers for time sensitive tests such as sexually transmissible diseases and other infections will drive the market for POC molecular test devices. Ease of use is a plus for hospital labs. Worldwide, lab budgets are being cut for test send-outs and there are not enough trained technologists to run molecular tests in their present configuration. The new pharma model tailors therapy to the individual's particular disease physiology often determined by the results of a diagnostic test. So, more tests - molecular and immunoassays - will come to market, some will have a high price tag and some not. Price will not be the deciding factor. Test adoption in this scenario is based on performance data, contribution to patient outcome and cost/benefit analysis.

The World Market for Point of Care (POC) Diagnostics examines the main issues and trends affecting the POC market. These include:

  • Wearables
  • Breath Test Advances
  • Reimbursement Challenges
  • Competition
  • POC and Molecular Diagnostics
  • POC and Biosensors and Microfluidics
  • POC Connectivity
  • The Emergence of Non-invasive Technologies

5 The report's geographic scope is worldwide with information for specific geographical regions; world demographics, and other general issues affecting the market. The market summary includes market analysis by product and region and a competitive analysis of leading providers. Large and small companies are involved in the development and/or marketing of POC testing. The market is considered evolving with growth opportunity. Developing and developed markets alike have room to grow due to an aging population worldwide. Among the top and/or innovative competitors discussed within the report's corporate profiles are:

  • Abaxis
  • Abbott Labs
  • Abingdon Health
  • AccuBioTech Co
  • Accriva
  • ACON
  • Aerscher Diagnostics
  • Alere
  • Alfa Scientific Designs
  • American Bio Medica
  • Aquila Diagnostic System
  • Arkray
  • Artron Laboratories
  • Atlas Genetics
  • Atlas Link Biotech
  • Ativa Medical Corp
  • Autobio Diagnostics
  • Augurix Diagnostic
  • Axxin
  • Beckman Coulter
  • bioLytical Laboratories
  • Biomerica
  • Bioptix
  • biOracle Limited
  • BioMedomics
  • Biomeme
  • bioMerieux SA
  • Biosensia
  • Calypte Biomedical Corp
  • Cephid
  • Chembio Diagnostic Systems
  • Church & Dwight
  • Dakaria Diagnostics
  • Danaher Corporation
  • DexCom
  • DNA Electronics
  • Dragerwerks
  • Eiken Chemical
  • EKF Diagnostics
  • Enigma Diagnostics
  • Enterix
  • Entopsis
  • Epistem/Genedrive
  • EY Laboratories
  • Exalenz Bioscience
  • FABPulous B.V.
  • Fio Corp
  • Helena Labs
  • Hema Diagnostic System
  • InSilixa
  • Instrumentation Laboratories
  • Jant Pharmacal
  • LamdaGen Corp
  • LifeScan
  • LifeSign
  • Macherey-Nagel
  • Magnasense Technologies
  • Mbio Diagnostics
  • Medix Biochemical
  • MedMira
  • Menarini Diagnostics
  • Meridian BioScience
  • Metaara Medical Technologies
  • Nova Biomedical
  • OPKO Health
  • OraSure
  • Ortho Clinical Diagnostics
  • Polymed Therapeutics
  • Polymedco
  • Polymer Technologies
  • QuantuMDx Group
  • Quidel
  • Radiometer Medical
  • Response Biomedical
  • Roche Diagnostics
  • Samsung Healthcare
  • Savyon Diagnostics
  • Sekisui Diagnostics
  • Siemens Healthcare
  • Siloam Biosciences
  • Spectral Medical
  • Sysmex
  • Trinity Biotech
  • Veredus Laboratories
  • Wave 80 Biosciences
  • Xagenic

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 30 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

Table of Contents

1: EXECUTIVE SUMMARY

  • INTRODUCTION
  • SCOPE AND METHODOLOGY
  • SIZE AND GROWTH OF THE MARKET
    • Table 1-1: Global POC Test Market, 2014-2021
  • TRENDS AFFECTING THE MARKET
  • COMPETITIVE OUTLOOK

2: INTRODUCTION AND OVERVIEW

  • POINT-OF-CARE DIAGNOSTICS TESTING
  • INDUSTRY REGULATIONS
  • POC INDUSTRY DRIVERS
    • Patient focused drivers
    • Medical/Healthcare related drivers
    • Technology drivers
    • Economic drivers
    • Other drivers
  • POC TEST TYPES
    • Blood
    • Urine
    • Saliva
    • Hair
    • Optical Technologies
    • Breath
  • CONDITIONS EVALUATED BY POC DIAGNOSTIC TESTING
    • Cancer
    • Cardiovascular Disease
    • Diabetes
    • Drug Abuse
    • Central Nervous System Stimulants
    • Prevalence and Number of Illicit Drug Users
    • The World Market for Point of Care Diagnostics
    • February ii 2017 © Kalorama Information
    • Table 2-1: Estimated Number and Prevalence of Drug Users by Region and Age (15-64) (Africa, North America, South America, Asia, Europe, Oceania, Global Total)
    • Infectious Disease
    • Pregnancy and Fertility
    • World Demographics
    • Table 2-2: World Population by Selected Geographical Region, 2010 - 2050 (Africa, Asia, Europe, North America, Oceania, Latin America, World)
    • Global Aging Population

3: POC BLOOD GLUCOSE TESTS

  • TYPES OF BLOOD GLUCOSE TESTING
    • Fasting Blood Sugar (FBS)
    • 2-Hour Postprandial Blood Sugar (PPBS)
    • Random Blood Sugar
    • Glucose Tolerance Test
    • Glucose Urine Test
    • Glycated Hemoglobin (HbA1c)
  • PRODUCTS
    • Blood Glucose Self-Testing
    • Table 3-1: Selected Glucose Self-Test Meter Innovations
    • Table 3-2: Selected Apps and Glucose Management IT
    • Continuous Self-Testing
    • Glycated Hemoglobin Tests
    • Professional
  • MARKET SIZE AND GROWTH
  • POC Glucose Self-Testing
  • POC Glucose Professional Testing
  • COMPETITIVE ANALYSIS
    • Figure 3-1: Global POC Glucose Test Manufacturers by Percent, 2016

4: POC BLOOD AND ELECTROLYTES TESTING MARKET

  • TYPES OF BLOOD AND ELECTROLYTES TESTS
    • Hemoglobin/Hematocrit
  • WBC
    • Blood Gases
    • Electrolytes
  • PRODUCTS
    • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2016
    • Table 4-2: Selected POC Hematology Analyzer Systems, 2016
  • MARKET SIZE AND GROWTH
    • Table 4-3: Global POC Blood and Electrolytes Testing Market Analysis, 2014-2021
  • POC Blood and Electrolyte Self-Testing
  • POC Blood and Electrolyte Professional Testing
    • Table 4-4: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2016-2021
  • COMPETITIVE ANALYSIS
    • Table 4-5: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2016
    • Figure 4-1: Global POC Blood and Electrolyte Testing Market Manufacturers by Percent, 2016

5: POC RAPID COAGULATION

  • PRODUCTS
    • Table 5-1: Selected POC Coagulation Innovations
    • Platelet Testing
    • Table 5-2: Selected Platelet Activity Test Innovations
  • MARKET SIZE AND GROWTH
    • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2014-2021
  • POC Rapid Coagulation Self-Testing
    • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2016-2021
  • POC Rapid Coagulation Professional Testing
  • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2016-2021
  • COMPETITIVE ANALYSIS
    • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2016
    • Figure 5-1: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers, 2016

6: POC RAPID CARDIAC MARKERS

  • PRODUCTS
  • MARKET SIZE AND GROWTH
    • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2016-2021
  • COMPETITIVE ANALYSIS
    • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2016 (in millions $)
    • Figure 6-1: Global POC Cardiac Test Manufacturers by Percent, 2016

7: POC SUBSTANCE ABUSE

  • PRODUCTS
    • Urine
    • Oral
    • Blood
    • Hair
  • MARKET SIZE AND GROWTH
  • POC Drugs of Abuse Self-Testing
  • POC Drugs of Abuse Professional Testing
    • The World Market for Point of Care Diagnostics
    • February iv 2017 © Kalorama Information
  • COMPETITIVE ANALYSIS
    • Table 7-1: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2016
    • Figure 7-1: Global POC Drug of Abuse Testing Manufacturers by Percent, 2016

8: POC PREGNANCY AND FERTILITY TESTING

  • PRODUCTS
    • Table 8-1: 2016 Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer's Instrument / Device / Assay
  • MARKET SIZE AND GROWTH
    • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2014-2021
  • POC Pregnancy and Fertility Self-Testing
    • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2016-2021
  • POC Pregnancy and Fertility Professional Testing
    • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2016-2021
  • COMPETITIVE ANALYSIS
    • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2016
    • Figure 8-1: Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2016

9: POC COLON CANCER SCREENING/FECAL OCCULT BLOOD TESTING

  • PRODUCTS
    • Table 9-1: Selected POC Colon Cancer Tests
  • MARKET SIZE AND GROWTH
    • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2014-2021 .. 119
  • POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
    • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2016-2021
  • POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
    • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2014-2019 (in millions of dollars)
  • COMPETITIVE ANALYSIS
    • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2016
    • Figure 9-1: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers (%), 2016

10: POC INFECTIOUS DISEASE TESTING

  • PRODUCTS
  • MARKET SIZE AND GROWTH
  • POC Infectious Disease Self-Testing
  • POC Infectious Disease Professional Testing
  • COMPETITIVE ANALYSIS
    • Figure 10-1: Global POC Infectious Disease Test Manufacturers by Percent, 2016

11: POC LIPID TESTING

  • PRODUCTS
  • MARKET SIZE AND GROWTH
    • Table 11-1: Global POC Cholesterol Testing Market Analysis, 2014-2021
  • POC Cholesterol Self-Testing
    • Table 11-2: POC Cholesterol Self-Testing Market Analysis, 2016-2021
  • POC Cholesterol Professional Testing
    • Table 11-3: POC Cholesterol Professional Testing Market Analysis, 2016-2021
  • COMPETITIVE ANALYSIS
    • Table 11-4: Global POC Cholesterol Testing Market, Revenues and Market Share of Leading Suppliers, 2016 (in millions $)
    • Figure 11-1: Global POC Cholesterol Testing Manufacturers by Percent, 2016

12: POC CANCER TUMOR MARKER TESTING

  • PRODUCTS
    • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
  • MARKET SIZE AND GROWTH
    • Table 12-2: Global POC Cancer Testing Market Analysis, 2014-2021
  • COMPETITIVE ANALYSIS
    • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2016 . 142
    • Figure 12-1: Global POC Cancer Testing Manufacturers by Percent, 2016

13: POC URINE STRIP TESTING

  • PRODUCTS
  • MARKET SIZE AND GROWTH
  • POC Urine Strip Self-Testing
  • POC Urine Test Strip Professional Testing
  • COMPETITIVE ANALYSIS
    • Figure 13-1: Global POC Urine Strip Testing Manufacturers by Percent, 2016

14: MISCELLANEOUS POC TESTING

  • MICROBIOLOGY
  • TSH
  • ALLERGY
  • AUTOIMMUNE
  • OTHERS
  • MARKET SIZE AND GROWTH
    • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2014-2021

15: ISSUES AND TRENDS

  • OVERVIEW
    • The World Market for Point of Care Diagnostics
    • February vi 2017 © Kalorama Information
  • WEARABLES
    • Table 15-1: Selected Wearable Devices
  • BREATH TEST ADVANCES
    • Table 15-2: Selected Disease Markers in Exhaled Breath
  • REIMBURSEMENT CHALLENGES
  • COMPETITION
  • POC AND MOLECULAR DIAGNOSTICS
    • Table 15-3: Market Available Molecular POC Diagnostic Platforms
  • POC AND BIOSENSORS AND MICROFLUIDICS
    • Table 15-4: Selected Biochip and Biosensor Players, 2016
  • POC CONNECTIVITY
  • THE EMERGENCE OF NON-INVASIVE TECHNOLOGIES
    • Saliva and Swab
    • Optical Techniques

16: TOTAL GLOBAL POC TESTING MARKET AND COMPETITOR ANALYSIS

  • MARKET OVERVIEW
    • Table 16-1: Global POC Test Market, 2014-2021
  • MARKET ANALYSIS BY PRODUCT CATEGORIES
    • Table 16-2: Global POC Testing Market Analysis by Product Category, 2016 (Professional, Self-Testing) .. 176
  • MARKET ANALYSIS BY SUBCATEGORY
  • POC Professional Testing
    • Table 16-3: Global POC Professional Testing Market Analysis by Product Subcategory, 2016 (Drugs of Abuse, Blood & Electrolytes, Glucose, Infectious Disease, Rapid Coagulation, Cardiac Markers, Fecal Occult Blood, Lipid, Pregnancy & Fertility, Miscellaneous, Urine Strip, Cancer, Total)
  • POC Self-Testing
    • Table 16-4: Global POC Self-Testing Market Analysis by Product Category, 2016 (Glucose, Pregnancy & Fertility, Fecal Occult Blood, Rapid Coagulation, Drugs of Abuse, Urine Strip, Infectious Disease, Lipid)
  • MARKET ANALYSIS BY COUNTRY
    • United States
    • Europe
    • Japan
    • Rest of World
    • Table 16-5: Global POC Testing Analysis by Region/Country, 2016 (United States, Europe, Japan, ROW, Total)
    • Figure 16-1: Global POC Testing Market Analysis Percent by Region/Country, 2016 (United States, Europe, Japan, ROW)
    • Table 16-6: Global POC Testing Market Analysis by European Region, 2016 (W. Europe, E. Europe)
    • Figure 16-2: Global POC Testing Market Analysis by European Region, 2016 (Germany, France, UK, Italy, Spain, Others)
    • Table 16-7: Global POC Testing Market Analysis by Rest of World Region/Country, 2016 (China, India, Brazil, Other, Total)
    • Figure 16-3: Global POC Testing Market Analysis by Rest of World Region/Country, 2016 (China, India, Brazil, Other)
  • MARKET CONCLUSIONS
    • Conclusion One
    • Conclusion Two
    • Conclusion Three
    • Conclusion Four
    • Conclusion Five
    • Conclusion Six
  • COMPETITIVE ANALYSIS
    • Table 16-8: Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2016
    • Figure 16-4: Global POC Testing Market Share by Leading Suppliers, 2016

17: CORPORATE PROFILES

  • OVERVIEW
  • ABAXIS, INC.
    • Table 17-1: Abaxis Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-2: Abaxis Revenue (2013-2016)
  • ABBOTT LABORATORIES
    • Table 17-3: Abbott Corporate Summary
    • Company Overview
    • Product
    • Performance Review
    • Table 17-4: Abbott Laboratories Revenue (2013-2016)
  • ABINGDON HEALTH, LTD.
    • Table 17-5: Abingdon Health Corporate Summary
    • Company Overview
    • Products
  • ACCUBIOTECH CO, LTD.
    • Table 17-6: AccuBioTech Summary
    • Company Overview
    • Products
  • ACCRIVA DIAGNOSTICS
    • Table 17-7: Accriva Diagnostics Summary
    • Company Overview
    • Products
  • ACON LABORATORIES, INC
    • Table 17-8: ACON Laboratories Corporate Summary
    • The World Market for Point of Care Diagnostics
    • February viii 2017 © Kalorama Information
    • Company Overview
    • Products
  • AERSCHER DIAGNOSTICS, LLC
    • Table 17-9: Aerscher Diagnostics Summary
    • Company Overview
    • Products
  • ALERE INC
    • Table 17-10: Alere Corporate Summary
    • Company Overview
    • Product
    • Performance Review
    • Table 17-11: Alere Revenue (2013-2016)
  • ALFA SCIENTIFIC DESIGNS, INC
    • Table 17-12: Alfa Scientific Summary
    • Company Overview
    • Products
  • AMERICAN BIO MEDICA CORPORATION
    • Table 17-13: American Bio Medica Summary
    • Company Overview
    • Products
  • AQUILA DIAGNOSTIC SYSTEMS, INC
    • Table 17-14: Aquila Diagnostic Systems Summary
    • Company Overview
  • ARKRAY
    • Table 17-15: Arkay Corporate Summary
    • Company Overview
    • Products
  • ARTRON LABORATORIES, INC
    • Table 17-16: Artron Laboratories Summary
    • Company Overview
  • ATLAS GENETICS LTD.
    • Table 17-17: Atlas Genetics Corporate Summary
    • Company Overview
    • Products
  • ATLAS LINK BIOTECH CO., LTD
    • Table 17-18: Atlas Link Biotech Summary
    • Company Overview
  • ATIVA MEDICAL CORPORATION
    • Table 17-19: Ativa Medical Summary
    • Company Overview
  • AUTOBIO DIAGNOSTICS CO., LTD
    • Table 17-20: Autobio Summary
    • Company Overview
  • AUGURIX DIAGNOSTIC
    • Table 17-21: Augurix Diagnostic Summary
    • Company Overview
  • AXXIN
    • Table 17-22: Axxin Summary
    • Company Overview
  • BECKMAN COULTER, INC
    • Table 17-23: Beckman Coulter Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-24: Beckman Coulter (2013-2016)
  • BIOLYTICAL LABORATORIES
    • Table 17-25: bioLytical Laboratories Summary
    • Company Overview
  • BIOMERICA
    • Table 17-26: Biomerica Summary
    • Company Overview
  • BIOPTIX, INC
    • Table 17-27: Bioptix Summary
    • Company Overview
  • BIORACLE LIMITED
    • Table 17-28: biOracle Summary
    • Company Overview
  • BIOMEDOMICS, INC
    • Table 17-29: BioMedomics Summary
    • Company Overview
  • BIOMEME, INC
    • Table 17-30: Biomeme Corporate Summary
    • Company Overview
  • BIOMERIEUX SA
    • Table 17-31: bioMerieux SA Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-32: bioMerieux Revenues (2013-2016)
  • BIOSENSIA
    • Table 17-33: Biosensia Summary
    • Company Overview
    • The World Market for Point of Care Diagnostics
    • February x 2017 © Kalorama Information
  • CALYPTE BIOMEDICAL CORPORATION
    • Table 17-34: Calypte Biomedical Summary
    • Company Overview
  • CEPHID
    • Table 17-35: Cephid Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-36: Cephid Revenues (2013-2016)
  • CHEMBIO DIAGNOSTIC SYSTEMS, INC.
    • Table 17-37: Chembio Diagnostic Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-38: Chembio Diagnostics Revenues (2013-2016)
  • CHURCH & DWIGHT CO. INC
    • Table 17-39: Church & Dwight Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-40: Church & Dwight Revenue (2013-2016)
  • DAKTARI DIAGNOSTICS
    • Table 17-41: Daktari Diagnostics Summary
    • Company Overview
  • DANAHER CORPORATION
    • Table 17-42: Danaher Corporation Summary
    • Company Overview
  • DEXCOM, INC
    • Table 17-43: DexCom Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-44: DexCom Revenue (2013-2016)
  • DNA ELECTRONICS LTD. (DNAE)
    • Table 17-45: DNA Electronics Corporate Summary
    • Company Overview
  • DRAGERWERK AG & CO. KGAA
    • Table 17-46: Dragerwerk Corporate Summary
    • Company Overview
    • Products
    • Company Financials
    • Table 17-47: Drager Revenue (2013-2016)
  • EIKEN CHEMICAL CO LTD.
    • Table 17-48: Eiken Chemical Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-49: Eiken Chemical Revenue (2013-2016)
  • EKF DIAGNOSTICS HOLDINGS PLC
    • Table 17-50: EKF Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-51: EKF Diagnostics Revenue (2013-2016)
  • ENIGMA DIAGNOSTICS, LTD.
    • Table 17-52: Enigma Diagnostics Corporate Summary
    • Company Overview
    • Products
  • ENTERIX, INC
    • Table 17-53: Enterix Corporate Summary
    • Company Overview
    • Products
  • ENTOPSIS
    • Table 17-54: Entopsis Corporate Summary
    • Company Overview
    • Products
  • EPISTEM/GENEDRIVE
    • Table 17-55: Epistem/Genedrive Corporate Summary
    • Company Overview
    • Products
    • EY LABORATORIES
    • Table 17-56: EY Laboratories Summary
  • Company Overview
  • EXALENZ BIOSCIENCE LTD.
    • Table 17-57: Exalenz Bioscience Summary
    • Company Overview
  • FABPULOUS B.V.
    • Table 17-58: FABPulous Corporate Summary
    • Company Overview
    • Products
  • FIO CORPORATION
    • Table 17-59: Fio Corporate Summary
    • The World Market for Point of Care Diagnostics
    • February xii 2017 © Kalorama Information
    • Company Overview
    • Products
  • HELENA LABORATORIES
    • Table 17-60: Helena Laboratories Corporate Summary
    • Company Overview
    • Products
  • HEMA DIAGNOSTIC SYSTEMS, LLC
    • Table 17-61: Hema Diagnostics Systems Corporate Summary
    • Company Overview
    • Products
  • INSILIXA, INC
    • Table 17-62: InSilixa Corporate Summary
    • Company Overview
    • Products
  • INSTRUMENTATION LABORATORY
    • Table 17-63: Instrumentation Laboratory Corporate Summary
    • Company Overview
    • Products
  • JANT PHARMACAL CORPORATION
    • Table 17-64: Jant Pharmacal Summary
    • Company Overview
    • Products
  • LAMDAGEN CORPORATION
    • Table 17-65: LamdaGen Corporate Summary
    • Company Overview
  • LIFESCAN, INC
    • Table 17-66: LifeScan Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-67: LifeScan Revenue (2013-2016)
  • LIFESIGN, LLC
    • Table 17-68: LifeSign Summary
    • Company Overview
  • MACHEREY-NAGEL GMBH & CO. KG
    • Table 17-69: Macherey-Nagel Corporate Summary
    • Company Overview
    • Products
  • MAGNASENSE TECHNOLOGIES
    • Table 17-70: Magnasense Technologies Summary
    • Company Overview
  • MBIO DIAGNOSTICS, INC
    • Table 17-71: Mbio Diagnostics Summary
    • Company Overview
  • MEDIX BIOCHEMICA
    • Table 17-72: Medix Biochemica Summary
    • Company Overview
    • Products
  • MEDMIRA, INC
    • Table 17-73: MedMira Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-74: MedMira Revenue (2013-2016)
  • MENARINI DIAGNOSTICS
    • Table 17-75: Menarini Diagnostics Summary
    • Company Overview
    • Products
  • MERIDIAN BIOSCIENCE, INC
    • Table 17-76: Meridian BioScience Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-77: Meridian Bioscience Revenue (2013-2016)
  • METAARA MEDICAL TECHNOLOGIES, INC
    • Table 17-78: Metaara Medical Technologies Summary
    • Company Overview
  • MICRONICS, INC
    • Table 17-79: Micronics Summary
    • Company Overview
  • NOVA BIOMEDICAL, CORP.
    • Table 17-80: Nova Biomedical Corporate Summary
    • Company Overview
    • Products
  • OPKO HEALTH, INC
    • Table 17-81: OPKO Health Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-82: OPKO Health Revenue (2013-2016)
  • ORASURE TECHNOLOGIES, INC.
    • Table 17-83: OraSure Technologies Corporate Summary
    • The World Market for Point of Care Diagnostics
    • February xiv 2017 © Kalorama Information
    • Company Overview
    • Products
    • Performance Review
    • Table 17-84: OraSure Revenue (2013-2016)
  • ORTHO CLINICAL DIAGNOSTICS
    • Table 17-85: Ortho Clinical Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-86: Ortho Clinical Diagnostics Revenue (2013-2016)
  • POLYMED THERAPEUTICS INC.
    • Table 17-87: Polymed Therapeutics Corporate Summary
    • Company Overview
    • Products
  • POLYMEDCO, INC
    • Table 17-88: Polymedco Corporate Summary
    • Company Overview
    • Products
  • POLYMER TECHNOLOGIES, INC (PTS DIAGNOSTICS)
    • Table 17-89: Polymer Technologies Corporate Summary
    • Company Overview
    • Products
  • QUANTUMDX GROUP LIMITED
    • Table 17-90: QuantuMDx Group Corporate Summary
    • Company Overview
    • Products
  • QUIDEL CORPORATION
    • Table 17-91: Quidel Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-92: Quidel Revenue (2013-2016)
  • RADIOMETER MEDICAL A/S
    • Table 17-93: Radiometer Medical Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-94: Radiometer Revenue (2013-2016)
  • RESPONSE BIOMEDICAL CORP
    • Table 17-95: Response Biomedical Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-96: Response Biomedical Revenue (2013-2016)
  • RHEONIX, INC
    • Table 17-97: Rheonix Corporate Summary
    • Company Overview
    • Products
  • ROCHE DIAGNOSTIC CORPORATION
    • Table 17-98: Roche Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-99: Roche Revenue (2013-2016)
  • SAMSUNG HEALTHCARE
    • Table 17-100: Samsung Healthcare Corporate Summary
    • Company Overview
    • Products
  • SAVYON DIAGNOSTICS
    • Table 17-101: Savyon Diagnostics Summary
    • Company Overview
    • Products
  • SEKISUI DIAGNOSTICS
    • Table 17-102: Sekisui Diagnostics Summary
    • Company Overview
    • Products
  • SIEMENS HEALTHINEERS
    • Table 17-103: Siemens Healthineers Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-104: Siemens Healthineers Revenue (2013-2016)
  • SILOAM BIOSCIENCES, INC
    • Table 17-105: Siloam Biosciences Summary
    • Company Overview
    • Products
  • SPECTRAL MEDICAL, INC
    • Table 17-106: Spectral Medical Summary
    • Company Overview
  • SYSMEX CORPORATION
    • Table 17-107: Sysmex Corporate Summary
    • Company Overview
    • The World Market for Point of Care Diagnostics
    • February xvi 2017 © Kalorama Information
    • Products
    • Performance Review
    • Table 17-108: Sysmex Revenue (2013-2016)
  • TRINITY BIOTECH PLC
    • Table 17-109: Trinity Biotech Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 17-110: Trinity Biotech Revenue (2013-2016)
  • VEREDUS LABORATORIES PTE LTD
    • Table 17-111: Veredus Labs Corporate Summary
    • Company Overview
    • Products
  • WAVE 80 BIOSCIENCES
    • Table 17-112: Wave 80 Biosciences Summary
    • Company Overview
  • XAGENIC
    • Table 17-113: Xagenic Corporate Summary
    • Company Overview
    • Products
Back to Top